Psychiatry has long been prone to fads. The main reason is that mental illness is poorly understood and can be difficult to treat. Most diagnostic fads have involved the extension of well-known categories into broader spectra. The most prominent treatment fads have involved the overuse of pharmacological interventions and a proliferation of methods for psychotherapy. The best antidote to fads is a commitment to evidence-based psychiatry.
BestJ.Flavor of the month: Why smart people fall for fads. Berkley (CA): University of California Press; 2006.
2.
MacKayC.Extraordinary popular delusions and the madness of crowds. New York (NY): Harmony Books; 1980. First published in 1841.
3.
GardnerM.Fads and fallacies in the name of science. 2nd, revised and expanded ed. Mineola (NY): Dover; 1957.
4.
MagnerLN. A history of medicine. New York (NY): Taylor and Francis; 2005.
5.
ShorterE.A history of psychiatry: From the era of the asylum to the age of Prozac. New York (NY): John Wiley & Sons, Inc; 1997.
6.
ValensteinES. Great and desperate cures. New York (NY): Basic; 1986.
7.
HuxleyTH. The quotations page. Quotations by author. Thomas T Huxley [Internet]. [place of publication unknown]: QuotationsPage.com and Michael Moncur; 1994–2013 [cited 2011 Aug 15]. Available from: http://www.quotationspage.com/quotes/ Thomas_H._Huxley.
FestingerL.A theory of cognitive dissonance. Stanford (CA): Stanford University Press; 1957.
10.
OswaldMEGrosjeanS.Confirmation bias. In: PohlE, editor. Cognitive illusions: A handbook on fallacies and biases in thinking, judgement and memory. Hove (GB): Psychology Press; 2004. p 79–96.
11.
HaidtJ.The righteous mind. New York (NY): Pantheon; 2012.
12.
TverskyAKahnemanD.Availability: A heuristic for judging frequency and probability. In: KahnemanDSlovicPTverskyA, editors. Judgment under uncertainty: Heuristics and biases. Cambridge (GB): Cambridge University Press; 1984. p 38–55.
13.
KahnemanD.Thinking, fast and slow. New York (NY): Farrar, Straus & Giroux; 2011.
14.
LevyDANailPR. Contagion: A theoretical and empirical review and reconceptualization. Genet Soc Gen Psychol Monogr. 1993;119:233–284.
15.
RobinsEGuzeSB. Establishment of diagnostic validity in psychiatric illness: Its application to schizophrenia. Am J Psychiatry. 1970;126:107–111.
16.
UherRRutterM.Basing psychiatric classification on scientific foundation: Problems and prospects. Int Rev Psychiatry. 2012;24:591–605.
17.
CooperJEKendellREGurlandBJ. Psychiatric diagnosis in New York and London. London (GB): Oxford University Press; 1972.
18.
American Psychiatric Association (APA). Diagnostic and statistical manual of mental disorder. 3rd ed.Washington (DC): APA; 1980.
19.
MoncrieffJ.The myth of the chemical cure. London (GB): Palgrave Macmillan; 2008.
20.
ParkerG.Beyond major depression. Psychol Med. 2005;35:467–474.
21.
ParkerGFinkMAkiskalHWhither melancholia? The case for its classification as a distinct mood disorder. Am J Psychiatry. 2010;167:745–767.
22.
KirschIDeaconBJHuedo-MedinaTBInitial severity and antidepressant benefits: A meta-analysis of data submitted to the Food and Drug Administration. PLoS Med. 2008;5:e45.
23.
ShorterEHealyD.Shock therapy: A history of electroconvulsive treatment in mental illness. New Brunswick (NJ): Rutgers University Press; 2007.
24.
HorwitzAVWakefieldJC. The loss of sadness: How psychiatry transformed normal sorrow into depressive disorder. New York (NY): Oxford University Press; 2007.
25.
HorwitzAVWakefieldJC. What we have to fear: Psychiatry's transformation of natural anxieties into mental disorders. New York (NY): Oxford University Press; 2012.
26.
ThombsBDCoyneJCCuijpersPRethinking recommendations for screening for depression in primary care. CMAJ. 2012;184:413–418.
27.
MoffittTECaspiATaylorAHow common are common mental disorders? Evidence that lifetime prevalence rates are doubled by prospective versus retrospective ascertainment. Psychol Med. 2009;40:899–909.
28.
AkiskalHSMcKinneyWTJr.Depressive disorders: Toward a unified hypothesis. Science. 1973;182:20–29.
29.
PrattLABrodyDJGuQ.Antidepressant use in persons aged 12 and over: United States, 2005–2008. NCHS [National Center for Health Statistics] data brief, no 76. Hyattsville (MD): NCHS; 2011.
30.
KraepelinE.Manic-depressive insanity and paranoia. BarclayRM, translator. RobertsonGM, editor. Edinburgh (GB): E and S Livingstone; 1921.
31.
GoodwinFKJamisonK.Manic-depressive illness: Bipolar disorder and recurrent depression. 2nd ed.New York (NY): Oxford University Press; 2007.
32.
ParkerG, editor. Bipolar-II disorder. Modeling, measuring and managing. 2nd ed.Cambridge (GB): Cambridge University Press; 2012.
33.
ParisJ.The bipolar spectrum: A critical perspective. Harv Rev Psychiatry. 2009;17:206–213.
34.
ParisJ.The bipolar spectrum—diagnosis or fad?New York (NY): Routledge; 2012.
35.
AkiskalHS. The bipolar spectrum—the shaping of a new paradigm in psychiatry. Curr Psychiatry Rep. 2002;4:1–3.
36.
MerikangasKRAkiskalHSAngstJLifetime and 12–month prevalence of bipolar spectrum disorder in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2007;64:543–552.
37.
AngstJAzorinJMBowdenCLPrevalence and characteristics of undiagnosed bipolar disorders in patients with a major depressive episode. Arch Gen Psychiatry. 2011;68:791–798.
38.
AkiskalHSAkiskalKKLancrenonSValidating the bipolar spectrum in the French National EPIDEP Study: Overview of the phenomenology and relative prevalence of its clinical prototypes. J Affect Disord. 2006;96:197–205.
39.
DuffyA.Does bipolar disorder exist in children? A selective review. Can J Psychiatry. 2007;52:409–417.
40.
ParisJ.The use and misuse of psychiatric drugs. London (GB): John Wiley & Sons, Ltd; 2010.
41.
BarkleyR.Attention-deficit hyperactivity disorder, third edition: A handbook for diagnosis and treatment. New York (NY): Guilford; 2006.
42.
LeungAKLemayJF. Attention deficit hyperactivity disorder: An update. Adv Ther. 2003;20:305–318.
43.
WeissGHechtmanL.Hyperactive children grown up: ADHD in children, adolescents, and adults. 2nd ed.New York (NY): Guilford; 1993.
44.
BergerM.Psychological assessment. In: SkuseDBruceHDowndneyH, editors. Child psychology and psychiatry: Frameworks for practice. 2nd ed.New York (NY): John Wiley; 2011. p 250–255.
45.
CumynLFrenchLHechtmanL.Comorbidity in adults with attention-deficit hyperactivity disorder. Can J Psychiatry. 2009;54:673–683.
46.
RapoportJLBuchsbaumMSZahnTPDextroamphetamine: Cognitive and behavioral effects in normal prepubertal boys. Science. 1978;199:560–563.
47.
KimYSLeventhalBLKohY-JPrevalence of autism spectrum disorders in a total population sample. Am J Psychiatry. 2011;168:904–912.
48.
FombonneE.Is there an epidemic of autism?Pediatrics. 2005;107:411–412.
49.
SimeonDAbugelJ.Feeling unreal: Depersonalization disorder and the loss of the self. New York (NY): Oxford University Press; 2006.
50.
SeligmanRKirmayerLJ. Dissociative experience and cultural neuroscience: Narrative, metaphor and mechanism. Cult Med Psychiatry. 2007;32:31–64.
51.
PiperAMerskeyH.The persistence of folly: Critical examination of dissociative identity disorder. Part II. The defence and decline of multiple personality or dissociative identity disorder. Can J Psychiatry. 2004;49:678–683.
52.
RieberRW. The bifurcation of the self: The history and theory of dissociation and its disorders. New York (NY): Springer; 2006.
53.
NathanD.Sibyl exposed. New York (NY): Simon and Schuster; 2011.
54.
BrookeNSWiersgallaMSalzmanC.Atypical uses of atypical antipsychotics. Harv Rev Psychiatry. 2005;13:317–339.
55.
NelsonJCThaseMEKhanA.Are antidepressants effective?—what's a clinician to think?J Clin Psychiatry. 2008;69:1014–1015.
56.
ComerJSMojtabaiROlfsonM.National trends in the antipsychotic treatment of psychiatric outpatients with anxiety disorders. Am J Psychiatry. 2011;168:1057–1065.
57.
RushAJTrivediMHStewartJWCombining Medications to Enhance Depression Outcomes (CO-MED): Acute and long-term outcomes of a single-blind randomized study. Am J Psychiatry. 2011;168:698–701.
58.
MojtabaiROlfsonM.National trends in psychotropic medication polypharmacy in office-based psychiatry. Arch Gen Psychiatry. 2010;67:26–36.
59.
AvornJ.Powerful medicines: The benefits, risks, and costs of prescription drugs. New York (NY): Knopf; 2004.
60.
LewisSLiebermanJA. CATIE and CUtLASS: Can we handle the truth?Br J Psychiatry. 2008;192:161–163.
61.
CiprianiAAFurukawaTASalantiGComparative efficacy and acceptability of 12 new-generation antidepressants: A multiple-treatments meta-analysis. Lancet. 2009;373:746–758.
62.
BALANCE investigators and collaborators, GeddesJRGoodwinGMLithium plus valproate combination therapy versus monotherapy for relapse prevention in bipolar I disorder (BALANCE): A randomised open-label trial. Lancet. 2010;375:385–395.
63.
ParisJ.The fall of an icon. Toronto (ON): University of Toronto Press; 2005.
64.
LambertMJ. Bergin and Garfield's handbook of psychotherapy and behavior change. 6th ed.New York (NY): Wiley; 2013.
65.
WampoldBE. The great psychotherapy debate: Models, methods, and findings. Mahwah (NJ): Lawrence Erlbaum Associates; 2001.
66.
LilienfeldSOLynnSJLohrJM. Science and pseudoscience in clinical psychology. Washington (DC): American Psychological Association; 2001.
67.
BeckAT. The evolution of the cognitive model of depression and its neurobiological correlates. Am J Psychiatry. 2008;165:969–977.
68.
Evidence-Based Medicine Working Group. Evidence-based medicine: A new approach to teaching the practice of medicine. JAMA. 1992;268:2420–2425.
69.
IoannidisJPA. Why most published research findings are false. PLoS Med. 2005;2(8):e124.
70.
FirstMB. Paradigm shifts and the development of the diagnostic and statistical manual of mental disorders: Past experiences and future aspirations. Can J Psychiatry. 2010;55:692–700.
